News
Each time a cell divides, a small section of each chromosome's protective cap—the telomere—is worn away. Most cells use an ...
In a recent study, Associate Professor Makoto Ikeya (Department of Clinical Application) and his team of researchers ...
18hon MSN
Emiri Nakamura and Professor Koji Eto (Department of Clinical Application) has identified microtubule (MT) destabilization as ...
Alphalyse, a fast-growing Danish specialist contract research organization (CRO) that has developed GMP‑validated liquid‑chromatography mass‑spectrometry (LC‑MS) assays for host‑cell‑protein (HCP) ...
2d
Dealbreaker on MSNAbbVie’s $2.1B Acquisition Adds In Vivo Cell Therapy to Its Immunology & Inflammation PipelineAbbVie is acquiring Capstan Therapeutics, a startup with technology that enables in vivo engineering of immune cells.
The field of cellular immunotherapy has undergone a profound transformation in recent years, with autologous chimeric antigen receptor (CAR) T-cell therapies emerging as the standard-of-care option ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results